TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals Highlights New Preclinical Data for TERN-601 Program in Obesity at the ADA’s 83rd Annual Scientific Session and Upcoming Events

26 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference

06 июн 2023 16:30:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

02 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Publication of TERN-701 Trial-in-Progress Abstract for the 2023 ASCO Annual Meeting

25 май 2023 17:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at Upcoming Investor Conferences

24 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions

22 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates

15 май 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference

09 май 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

03 май 2023 16:05:01 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

27 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology

27 мар 2023 08:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences

02 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference

02 фев 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference

12 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference

05 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

23 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire

Terns Announces Pricing of $75 Million Public Offering

20 дек 2022 19:39:56 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

20 дек 2022 08:05:00 Источник Nasdaq GlobeNewswire

Terns Announces Proposed Public Offering

19 дек 2022 16:31:04 Источник Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit

01 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire